BELLUSCURA PLC LS -01
Belluscura plc develops and commercialize oxygen related medical device products in the United States. The company offers X-PLOR and DISCOV-R, a modular portable oxygen concentrator; and related accessories. Belluscura plc was incorporated in 2015 and is based in London, the United Kingdom.
BELLUSCURA PLC LS -01 (9VQ) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, BELLUSCURA PLC LS -01 (9VQ) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
BELLUSCURA PLC LS -01 - Net Assets Trend (None–None)
This chart illustrates how BELLUSCURA PLC LS -01's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for BELLUSCURA PLC LS -01 (None–None)
The table below shows the annual net assets of BELLUSCURA PLC LS -01 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to BELLUSCURA PLC LS -01's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
BELLUSCURA PLC LS -01 Competitors by Market Cap
The table below lists competitors of BELLUSCURA PLC LS -01 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Komarkcorp Bhd
KLSE:7017
|
$966.56K |
|
N. Leventeris S.A.
AT:LEBEK
|
$967.13K |
|
TARGET - Dusseldorf Stock Exchang
DU:DYH
|
$968.08K |
|
Lypsa Gems & Jewellery Limited
NSE:LYPSAGEMS
|
$968.81K |
|
PRYSMIAN - Dusseldorf Stock Exchang
DU:AEU
|
$966.13K |
|
Makara Mining Corp
PINK:MAKAF
|
$966.06K |
|
Track Group Inc
OTCQX:TRCK
|
$965.45K |
|
Schroder European Real Estate PLC
JSE:SCD
|
$965.14K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BELLUSCURA PLC LS -01's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares BELLUSCURA PLC LS -01's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently BELLUSCURA PLC LS -01 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares BELLUSCURA PLC LS -01's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $253,026,393
- Average return on equity (ROE) among peers: -74.55%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BELLUSCURA PLC LS -01 (9VQ) | €- | N/A | N/A | $966.40K |
| HeraMED Limited (1I4) | $-105.98K | 0.00% | 0.00x | $17.10 Million |
| Q-linea AB (publ) (3F80) | $163.19 Million | -164.65% | 0.41x | $9.23 Million |
| Guerbet SA (4G8) | $342.14 Million | 13.51% | 1.79x | $44.77 Million |
| Scandinavian Real Heart AB (Publ) (7820) | $111.29 Million | -9.42% | 0.06x | $4.77 Million |
| aap Implantate AG (AAQ1) | $54.78 Million | 26.71% | 0.17x | $9.65 Million |
| Carmat SA (CXT) | $7.48 Million | -557.76% | 3.92x | $1.62 Million |
| elexxion AG (E8X) | $-0.01 | 0.00% | 0.00x | $199.10K |
| AETHLON MEDIC.NEW DL-001 (EJU) | $15.06 Million | -79.86% | 0.16x | $446.12K |
| Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) | $139.44 Million | 15.79% | 0.97x | $610.05 Million |
| Gaush Meditech Ltd (F7Y) | $1.70 Billion | 10.23% | 0.68x | $29.55 Million |